Davis A R
Neuropathology Department, Royal Hallamshire Hospital, Sheffield, England, UK.
Br J Biomed Sci. 1996 Jun;53(2):157-61.
Node-negative breast cancer has become a major public health problem due to an increase in detection rates, and therefore clinical research in this field is expanding. In order to supply the correct therapy to an individual patient, the need for additional prognostic and predictive factors has led to identification of a plethora of potentially useful markers. However, no single prognostic marker currently available can give unequivocal information on prognosis and subsequent therapy.
由于检出率的提高，淋巴结阴性乳腺癌已成为一个重大的公共卫生问题，因此该领域的临床研究正在不断扩展。为了给个体患者提供正确的治疗，对额外的预后和预测因素的需求促使人们识别出了大量潜在有用的标志物。然而，目前可用的单一预后标志物都无法提供关于预后和后续治疗的确切信息。
